SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-096522
Filing Date
2023-12-18
Accepted
2023-12-18 16:30:36
Documents
16
Period of Report
2023-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190179-8k_lucyscien.htm   iXBRL 8-K 39828
2 FORM OF NOTE ea190179ex4-1_lucyscien.htm EX-4.1 174223
3 FORM OF WARRANT ea190179ex4-2_lucyscien.htm EX-4.2 61074
4 FORM OF SECURITIES PURCHASE AGREEMENT ea190179ex10-1_lucyscien.htm EX-10.1 140351
5 FORM OF SECURITY AND PLEDGE AGREEMENT ea190179ex10-2_lucyscien.htm EX-10.2 95445
  Complete submission text file 0001213900-23-096522.txt   810586

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lsdi-20231212.xsd EX-101.SCH 3033
7 XBRL LABEL FILE lsdi-20231212_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE lsdi-20231212_pre.xml EX-101.PRE 22371
10 EXTRACTED XBRL INSTANCE DOCUMENT ea190179-8k_lucyscien_htm.xml XML 3329
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-41616 | Film No.: 231494180
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)